Nanjing Hicin Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 379.21 million compared to CNY 453.52 million a year ago. Revenue was CNY 379.21 million compared to CNY 453.52 million a year ago.

Net income was CNY 20.08 million compared to CNY 28.23 million a year ago. Basic earnings per share from continuing operations was CNY 0.1674 compared to CNY 0.2353 a year ago. Diluted earnings per share from continuing operations was CNY 0.1674 compared to CNY 0.2353 a year ago.